Antibody Cocktail Treatment Given to 40 Patients in Hyderabad, Symptoms Vanished in 24 Hours: Doctor

The patients who have undergone the therapy are advised to get vaccinated only after three months due to the presence of high levels of antibodies after the procedure.

Published date india.com Published: June 12, 2021 11:34 PM IST
Experts say that the monoclonal antibody could prove to be a game-changer in times to come if used at the appropriate time.
Experts say that the monoclonal antibody could prove to be a game-changer in times to come if used at the appropriate time. (Representational Image)

New Delhi: Asian Institute of Gastroenterology, Hyderabad is witnessing what could be a milestone in treatment of coronavirus disease. The institute is carrying out one of the largest studies to find out if the therapy is effective against the highly infectious Delta variant. As many as 40 Covid patients were given a single-dose drug cocktail of monoclonal antibodies here, reports NDTV. “In 24 hours, they recovered from clinical symptoms like fever, malaise etc,” said chairperson of the hospital, Dr Nageshwar Reddy.

“Studies from the US have shown that this is effective against the British variant, Brazilian and South African variants also. No one has tested it against the Delta variant we have here. So what we are doing is that we are parallelly testing whether it is effective against the mutant virus. Results that we have now in 40 patients who we analysed after one week. almost in 100 per cent (cases), the virus disappeared when we did RT-PCR(sic),” said Dr Reddy.

Was given to former US president Donald Trump

The monoclonal antibody therapy is said to reduce the severity of the disease in patients with mild to moderate symptoms. It came into limelight after it was given to former US president Donald Trump when he tested positive for COVID-19 last year. The single dose cocktail of antibodies was given to patients within 3-7 days of infection.

Casirivimab and Indevimab are the two medicines that go into the drug cocktail for the monoclonal antibody therapy, costing around ₹ 70,000 or 1000 US dollars in India, whereas the cost for the therapy in the US is about 20,000 dollars. However, the demand for the therapy has been growing despite the cost, but doctors warn this cannot be overused. “We should not misuse (the therapy). Has to be given only under specific indication as authorised by the ministry of health under EUA because if it is overused, more mutant viruses can come. It has to be carefully used in selective populations,” said Dr Reddy.

Add India.com as a Preferred SourceAdd India.com as a Preferred Source

The patients who have undergone the therapy are advised to get vaccinated only after three months due to the presence of high levels of antibodies after the procedure.

Also Read:

For breaking news and live news updates, like us on Facebook or follow us on Twitter and Instagram. Read more on Latest India News on India.com.

By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts Cookies Policy.